Cargando…

Volumetric changes in subcortical structures following repeated ketamine treatment in patients with major depressive disorder: a longitudinal analysis

Abnormal subcortical structures have been associated with major depressive disorder (MDD) and could be reversed by antidepressant treatment. To date no study has examined the relationship between subcortical volumes and repeated ketamine treatment. The current study investigated volume changes in sp...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhou, Yan-Ling, Wu, Feng-Chun, Liu, Wei-Jian, Zheng, Wei, Wang, Cheng-Yu, Zhan, Yan-Ni, Lan, Xiao-Feng, Ning, Yu-Ping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7400625/ https://www.ncbi.nlm.nih.gov/pubmed/32747631 http://dx.doi.org/10.1038/s41398-020-00945-9

Ejemplares similares

Association of VEGF With Antianhedonic Effects of Repeated-Dose Intravenous Ketamine in Treatment-Refractory Depression
por: Zheng, Wei, et al.
Publicado: (2021)

Alterations of multiple peripheral inflammatory cytokine levels after repeated ketamine infusions in major depressive disorder
por: Zhan, Yanni, et al.
Publicado: (2020)

Association between plasma levels of BDNF and the antisuicidal effects of repeated ketamine infusions in depression with suicidal ideation
por: Zheng, Wei, et al.
Publicado: (2020)

Gender differences in the antianhedonic effects of repeated ketamine infusions in patients with depression
por: Zheng, Wei, et al.
Publicado: (2022)

A comparison of the antianhedonic effects of repeated ketamine infusions in melancholic and non-melancholic depression
por: Zheng, Wei, et al.
Publicado: (2022)

Functional connectivity of the amygdala and the antidepressant and antisuicidal effects of repeated ketamine infusions in major depressive disorder
por: Liu, Haiyan, et al.
Publicado: (2023)

Plasma VEGF Concentrations and Ketamine's Effects on Suicidal Ideation in Depression With Suicidal Ideation
por: Zheng, Wei, et al.
Publicado: (2022)

Plasma BDNF concentrations and the antidepressant effects of six ketamine infusions in unipolar and bipolar depression
por: Zheng, Wei, et al.
Publicado: (2021)

Association of plasma VEGF levels and the antidepressant effects of ketamine in patients with depression
por: Zheng, Wei, et al.
Publicado: (2021)

Baseline Plasma BDNF Levelsare Associated with Antianhedonic Effects of Repeated-Dose Intravenous Ketamine in Major Depressive Disorder
por: Zheng, Wei, et al.
Publicado: (2023)

The genetic organization of longitudinal subcortical volumetric change is stable throughout the lifespan
por: Fjell, Anders Martin, et al.
Publicado: (2021)

Volumetric assessment and longitudinal changes of subcortical structures in formalinized Beagle brains
por: Del Signore, Francesca, et al.
Publicado: (2022)

Neurocognitive effects of six ketamine infusions and the association with antidepressant effects in treatment-resistant bipolar depression: a preliminary study
por: Zheng, Wei, et al.
Publicado: (2020)

Subcortical volumetric abnormalities in bipolar disorder
por: Hibar, D P, et al.
Publicado: (2016)

Identifying common and distinct subcortical volumetric abnormalities in 3 major psychiatric disorders: a single-site analysis of 640 participants
por: Tu, Pei-Chi, et al.
Publicado: (2022)

Safety of Repeated Administration of Parenteral Ketamine for Depression
por: Feifel, David, et al.
Publicado: (2020)

The functional connectivity of the middle frontal cortex predicts ketamine’s outcome in major depressive disorder
por: Zhang, Fan, et al.
Publicado: (2022)

The R-Stereoisomer of Ketamine as an Alternative for Ketamine for Treatment-resistant Major Depression
por: Hashimoto, Kenji
Publicado: (2014)

Volumetric and Diffusion Abnormalities in Subcortical Nuclei of Older Adults With Cognitive Frailty
por: Wan, Mingyue, et al.
Publicado: (2020)

Cortical thickness and subcortical structure volume abnormalities in patients with major depression with and without anxious symptoms
por: Zhao, Ke, et al.
Publicado: (2017)

Frontal-Subcortical Volumetric Deficits in Single Episode, Medication-Naïve Depressed Patients and the Effects of 8 Weeks Fluoxetine Treatment: A VBM-DARTEL Study
por: Kong, Lingtao, et al.
Publicado: (2014)

Heritability of Subcortical Volumetric Traits in Mesial Temporal Lobe Epilepsy
por: Alhusaini, Saud, et al.
Publicado: (2013)

Volumetric Reductions of Subcortical Structures and Their Localizations in Alcohol-Dependent Patients
por: Shim, Jae-Hyuk, et al.
Publicado: (2019)

Asymmetry in cortical thickness and subcortical volume in treatment-naïve major depressive disorder
por: Zuo, Zhiwei, et al.
Publicado: (2018)

Combined fractional anisotropy and subcortical volumetric deficits in patients with mild-to-moderate depression: Evidence from the treatment of antidepressant traditional Chinese medicine
por: Li, Yuan, et al.
Publicado: (2022)

The Effect of Ketamine on Electrophysiological Connectivity in Major Depressive Disorder
por: Nugent, Allison C., et al.
Publicado: (2020)

Ketamine in Major Depressive Disorder: Mechanisms and Future Perspectives
por: Shin, Cheolmin, et al.
Publicado: (2020)

Increased Activity Imbalance in Fronto-Subcortical Circuits in Adolescents with Major Depression
por: Jiao, Qing, et al.
Publicado: (2011)

Microstructural Abnormalities in Subcortical Reward Circuitry of Subjects with Major Depressive Disorder
por: Blood, Anne J., et al.
Publicado: (2010)

Subcortical brain alterations in major depressive disorder: findings from the ENIGMA Major Depressive Disorder working group
por: Schmaal, L, et al.
Publicado: (2016)

Subcortical shape alterations in major depressive disorder: Findings from the ENIGMA major depressive disorder working group
por: Ho, Tiffany C., et al.
Publicado: (2020)

Antianhedonic Effect of Repeated Ketamine Infusions in Patients With Treatment Resistant Depression
por: Wilkowska, Alina, et al.
Publicado: (2021)

Volumetric and Shape Analysis of the Subcortical Regions in Schizophrenia Patients: A Pilot Study
por: Jamea, Abdullah Abu, et al.
Publicado: (2019)

Modulation of the functional connectome in major depressive disorder by ketamine therapy
por: Sahib, Ashish K., et al.
Publicado: (2022)

Effects of ketamine in electroconvulsive therapy for major depressive disorder: meta-analysis of randomised controlled trials
por: Li, Xiao-Mei, et al.
Publicado: (2020)

Compressed primary‐to‐transmodal gradient is accompanied with subcortical alterations and linked to neurotransmitters and cellular signatures in major depressive disorder
por: Xiao, Yang, et al.
Publicado: (2023)

On the safety of repeated ketamine infusions for the treatment of depression: Effects of sex and developmental periods
por: Strong, C.E., et al.
Publicado: (2018)

Local shape volume alterations in subcortical structures of suicide attempters with major depressive disorder
por: Kang, Wooyoung, et al.
Publicado: (2020)

Efficacy of different doses of ketamine as a bolus in major depressive disorder
por: Kheirkhah, Farzan, et al.
Publicado: (2018)

Could ketamine be the answer to treating treatment-resistant major depressive disorder?
por: Ramadan, Abdullah Mohammed, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_9hg516n8qb0nalktvqm51nup31